1-20 of 75
Eva Corey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 651: Combination of the androgen receptor inhibitor darolutamide and the PI3K inhibitor copanlisib leads to improved anti-tumor efficacy and apoptosis in prostate cancer models

Tatsuo Sugawara, Holly NGuyen, Eva Corey, Ekaterina Nevedomskaya, Oliver Politz, Dominik Mumberg, Bernard Haendler
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 651.
DOI: https://doi.org/10.1158/1538-7445.AM2022-651
Published: 15 June 2022
View article
Journal Articles

Abstract 2411: Di-ganglioside GD2 expression and role in promoting tumorigenicity in prostate cancer

Aaqib M. Bhat, Bhopal C. Mohapatra, Insha Mushtaq, Sukanya Chakraborty, Samikshan Dutta, Sameer Mirza, Matthew D. Storck, Subodh M. Lele, Ming-Fong Lin, Bruce J. Trock, Karen S. Sfanos, Colm Morrissey, Eva Corey, Jonathan Melamed, Leah Cook, Kaustubh Datta, Jane Meza, Jawed Siddiqui, Surinder K. Batra, Vimla Band, Hamid Band
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2411.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2411
Published: 15 June 2022
View article
Journal Articles

Abstract 273: Prostate cancer metastasis induces irregular bone formation associated to specific androgen dependent phenotypes

Felipe Eltit, Qiong Wang, Raphaële Charest-Morin, Colm Morrissey, Eva Corey, Rizhi Wang, Michael E. Cox
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 273.
DOI: https://doi.org/10.1158/1538-7445.AM2022-273
Published: 15 June 2022
View article
Journal Articles

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung-Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2021) 81 (18): 4736–4750.
DOI: https://doi.org/10.1158/0008-5472.CAN-21-0307
Published: 15 September 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 1141: CDK9 inhibition is selective for transcriptionally addicted tumors harboring MYC genomic amplifications

Melinda A. Day, Nikolaus D. Obholzer, Akanksha Pandey, Tom Chen, Tong Liang, Rosa A. Villagomez, Mulini Pingili, Jost V. Koren, David B. Freeman, Holly M. Nguyen, Jennifer L. Conor, Eva Corey, Matthew G. Reese, Andrew Boghossian, Brienne Engel, Melissa M. Ronan, Jennifer A. Roth, Joesph P. Vacca, Peter B. Rahl, Marius S. Pop, Benjamin W. Trotter, Charles Y. Lin, Jorge C. DiMartino, Pavan Kumar, Douglas C. Saffran
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1141.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1141
Published: 01 July 2021
View article
Journal Articles

Abstract 1458: Targeting fibroblast growth factor receptors in castration-resistant prostate cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Holly M. Nguyen, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1458.
DOI: https://doi.org/10.1158/1538-7445.AM2021-1458
Published: 01 July 2021
View article
Journal Articles

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

Ali Ghoochani, En-Chi Hsu, Merve Aslan, Meghan A. Rice, Holly M. Nguyen, James D. Brooks, Eva Corey, Ramasamy Paulmurugan, Tanya Stoyanova
Journal: Cancer Research
Cancer Res (2021) 81 (6): 1583–1594.
DOI: https://doi.org/10.1158/0008-5472.CAN-20-3477
Published: 15 March 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 3083: Selective inhibition of transcription factor BRN2 as a treatment strategy for Small Cell Prostate Cancer

Daksh Thaper, Ravi Munuganti, Adeleke Aguda, Soojin Kim, Shungyu Ku, Sahil Kumar, Sepideh Vahid, Shaghayegh Nouruzi, Olena Sivak, Dwaiyapan Ganguli, Colm Morrissey, Eva Corey, Himisha Beltran, Amina Zoubeidi
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3083.
DOI: https://doi.org/10.1158/1538-7445.AM2020-3083
Published: 15 August 2020
View article
Journal Articles

Abstract 4127: Niraparib is active against prostate xenograft models that are wild type or defective for DNA damage repair genes

Linda A. Snyder, Krista Menard, Georges Habineza Ndikuyeze, Holly M. Nguyen, Anna Hughes, Lorraine Angelillo, Gerald Chu, Jenny Driscoll, Rebecca Hawkins, Eva Corey
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4127.
DOI: https://doi.org/10.1158/1538-7445.AM2020-4127
Published: 15 August 2020
View article
Journal Articles

Abstract 924: The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models

Pascale Lejeune, Antje Wengner, Simon J. Baumgart, Ekaterina Nevedomskaya, Eva Corey, Dominik Mumberg, Bernard Haendler
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 924.
DOI: https://doi.org/10.1158/1538-7445.AM2019-924
Published: 01 July 2019
View article
Journal Articles

Abstract LB-030: Interferon signaling contributes to prostate cancer drug resistance

Supreet Agarwal, Kerry McGowen, Fathi Elloumi, Maggie Cam, Mike Beshiri, Eva Corey, Kathleen Kelly
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-030.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-030
Published: 01 July 2019
View article
Journal Articles

Abstract 59: The pioneer transcription factor FOXA2 regulates integrin alpha 1 expression controlling prostate cancer bone colonization

Zachary M. Connelly, Shu Yang, Nazih Khater, A. Wayne Orr, Renjie Jin, David Degraff, Colm Morrissey, Eva Corey, Robert Matusik, Xiuping Yu
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 59.
DOI: https://doi.org/10.1158/1538-7445.AM2019-59
Published: 01 July 2019
View article
Journal Articles

Abstract 2962: Targeting BCL2 as a therapeutic strategy in neuroendocrine prostate cancer

Alexandra N. Corella, Jared M. Lucas, Arja Kaipainen, Ilsa M. Coleman, Colm Morrissey, Eva Corey, Paul Nghiem, David MacPherson, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2962.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2962
Published: 01 July 2019
View article
Journal Articles

Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Bryce Lakely, Lori Kollath, Daniel W. Lin, Lawrence D. True, Eva Corey, Peter S. Nelson, Colm Morrissey
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4392.
DOI: https://doi.org/10.1158/1538-7445.AM2019-4392
Published: 01 July 2019
View article
Journal Articles

Abstract 379: Supraphysiological testosterone inhibits tumor growth and is associated with inhibition of ARV7 signaling and DNA damage response in preclinical models of enzalutamide-resistant prostate cancer

Hung-Ming Lam, Mark P. Labrecque, Holly M. Nguyen, Lisha G. Brown, Ilsa M. Coleman, Roman Gulati, Bryce Lakely, Daniel Sondheim, Brett Marck, Alvin M. Matsumoto, Elahe A. Mostaghel, Michael T. Schweizer, Peter S. Nelson, Eva Corey
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 379.
DOI: https://doi.org/10.1158/1538-7445.AM2019-379
Published: 01 July 2019
View article
Journal Articles

Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer

Joshua W. Russo, Ce Gao, Swati S. Bhasin, Olga S. Voznesensky, Carla Calagua, Seiji Arai, Peter S. Nelson, Bruce Montgomery, Elahe A. Mostaghel, Eva Corey, Mary-Ellen Taplin, Huihui Ye, Manoj Bhasin, Steven P. Balk
Journal: Cancer Research
Cancer Res (2018) 78 (22): 6354–6362.
DOI: https://doi.org/10.1158/0008-5472.CAN-18-0687
Published: 15 November 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Colm Morrissey, Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas, Roger T. Coleman, Robin Tharakan, Daniella Bianchi-Frias, Ruth F. Dumpit, Arja Kaipainen, Alexandra N. Corella, Yu Chi Yang, Michael D. Nyquist, Elahe Mostaghel, Xiaotun Zhang, Eva Corey, Lisha G. Brown, Holly M. Nguyen, Michael Schweizer, Lawrence D. True, Paul S. Rennie, Robert L. Vessella, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): IA21.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-IA21
Published: 14 August 2018
View article
Journal Articles

Abstract B051: PDX-derived and patient-derived prostate cancer organoids as a clinically relevant platform for translational research

Michael L. Beshiri, Caitlin M. Tice, Crystal Tran, Holly M. Nguyen, Adam G. Sowalsky, Supreet Agarwal, Keith H. Jansson, Kerry McGowen, Aian Neil Alilin, JuanJuan Yin, Fatima H. Karzai, William L. Dahut, Eva Corey, Kathleen Kelly
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): B051.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-B051
Published: 14 August 2018
View article
Journal Articles

Abstract B049: DNA damage echoes are key to prostate cancer susceptibility to supraphysiologic androgen levels

Payel Chatterjee, Jared M. Lucas, Michael D. Nyquist, Eva Corey, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): B049.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-B049
Published: 14 August 2018
View article
Journal Articles

Abstract A083: Cell adhesion to laminin, by integrin α6β1, mediates drug resistance to PI3K in castration-resistant prostate cancer through AR-dependent induction of BNIP3

Eric Nollet, Sourik Ganguly, Veronique Schulz, Eva Corey, Cindy K. Miranti
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): A083.
DOI: https://doi.org/10.1158/1538-7445.PRCA2017-A083
Published: 14 August 2018
View article